Formic Acid

Formic Acid

SCHEMBL4663844

COc1ccc(S(=O)(=O)Nc2ccc(Nc3cc(-c4nn(CCN(C)C)c5ccccc45)ncn3)cc2)cc1.O=CO

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 1/20 0.39
CCNT1 O60563 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CDK9 P50750 1/20 0.39
NPY5R Q15761 3/20 0.38
KIT P10721 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CACNA1B Q00975 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
LIMK2 P53671 1/20 0.37
BUB1 O43683 1/20 0.37
CDK4 P11802 1/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
HTR6 P50406 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4667436 0.78 KMT2A (0.40) TNNI3KCCNT1CDK9KMT2AHTR6
Formic Acid SCHEMBL4665678 0.76 HTT (0.41) KITCACNA1BABL1BCRHTR6
SCHEMBL4666216 0.76 ABCB1 (0.50) TNNI3KCCNT1CDK9NPY5RKIT
SCHEMBL4664297 0.74 HTR6 (0.54) ABL1BCRHTR6FAM20CEGFR
Formic Acid SCHEMBL4665739 0.74 MAPT (0.42) TNNI3KKITABL1BCRHTR6
SCHEMBL4665846 0.73 BACE1 (0.59) TNNI3KNPY5RMEN1KMT2ANPC1
Formic Acid SCHEMBL4665793 0.72 JAK1 (0.40) KITMEN1KMT2AHTR6KDM4E
Formic Acid SCHEMBL4664307 0.72 HTR6 (0.51) KITABL1BCRHTR6ALDH1A1
SCHEMBL4667504 0.72 BPTF (0.51) ABL1BCRHTR6EGFR
Formic Acid SCHEMBL4665702 0.71 ABL1 (0.48) KITABL1BCRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors ALTANA PHARMA AG (DE) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors MAP3K19, MAP3K6, MAP3K20 TNNI3K 25/4885CCNT1 217/4885CDK1 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.